federal_register: 2012-19036
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-19036 | Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT); Public Workshop | Notice | The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is announcing a 4-day public workshop entitled "Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT)." The purpose of this workshop is to provide a forum to consider issues related to endpoints that can support drug development in the following disease areas: Eosinophilic esophagitis, pediatric and adult inflammatory bowel disease, and parenteral nutrition-associated liver disease. | 2012-08-03 | 2012 | 8 | https://www.federalregister.gov/documents/2012/08/03/2012-19036/gastroenterology-regulatory-endpoints-and-the-advancement-of-therapeutics-great-public-workshop | https://www.govinfo.gov/content/pkg/FR-2012-08-03/pdf/2012-19036.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is announcing a 4-day public workshop entitled "Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT)." The purpose of this workshop is to... |